STOCK TITAN

Rodedawg Ind. Intl., Inc. Announces New Officers Appointment for Elixicure, LLC

Rhea-AI Impact
(Neutral)
Rhea-AI Sentiment
(Neutral)
Tags
Rodedawg International Industries, Inc. announces new officers appointment for Elixicure, , marking its entry into the $11 billion topical pain relief market. Future Market Insights research projects a 5.6% CAGR growth in global topical pain relief demand, reaching $19 billion by 2034. Jeff Byrne and Don Dedo join as key executives to drive Elixicure's expansion and market presence, reflecting Rodedawg's commitment to growth and success in the industry.
Rodedawg International Industries, Inc. annuncia la nomina di nuovi dirigenti per Elixicure, segnando così il suo ingresso nel mercato dei prodotti topici antidolorifici da 11 miliardi di dollari. Le ricerche di Future Market Insights prevedono una crescita del CAGR del 5,6% nella domanda globale di antidolorifici topici, con un valore che raggiungerà i 19 miliardi di dollari entro il 2034. Jeff Byrne e Don Dedo si uniscono come dirigenti chiave per guidare l'espansione e la presenza sul mercato di Elixicure, riflettendo l'impegno di Rodedawg verso la crescita e il successo nel settore.
Rodedawg International Industries, Inc. anuncia el nombramiento de nuevos directivos para Elixicure, marcando su entrada en el mercado de alivio del dolor tópico de 11 mil millones de dólares. Investigaciones de Future Market Insights proyectan un crecimiento CAGR del 5,6% en la demanda global de alivio del dolor tópico, alcanzando los 19 mil millones de dólares para 2034. Jeff Byrne y Don Dedo se incorporan como ejecutivos clave para impulsar la expansión y presencia en el mercado de Elixicure, reflejando el compromiso de Rodedawg con el crecimiento y éxito en la industria.
로디더그 인터내셔널 인더스트리즈, Inc.는 엘리크슈어의 새로운 임원 임명을 발표하며, 110억 달러 규모의 국소 통증 완화 시장에 진출했다고 밝혔습니다. 퓨처 마켓 인사이트의 연구에 따르면, 국소 통증 완화 수요는 2034년까지 190억 달러에 이를 것으로 예상되며, 연평균 성장률(CAGR)은 5.6%에 달할 것으로 전망됩니다. 제프 번과 돈 데도가 엘리크슈어의 확장과 시장 입지를 강화하기 위해 핵심 임원으로 합류하였으며, 이는 로디더그가 산업에서의 성장과 성공에 대한 헌신을 반영한 것입니다.
Rodedawg International Industries, Inc. annonce la nomination de nouveaux dirigeants pour Elixicure, marquant ainsi son entrée sur le marché des analgésiques topiques de 11 milliards de dollars. Les recherches de Future Market Insights prévoient une croissance du CAGR de 5,6 % de la demande mondiale en analgésiques topiques, atteignant 19 milliards de dollars d'ici 2034. Jeff Byrne et Don Dedo rejoignent en tant que cadres clés pour piloter l'expansion et la présence sur le marché d'Elixicure, reflétant l'engagement de Rodedawg envers la croissance et le succès dans l'industrie.
Rodedawg International Industries, Inc. kündigt die Ernennung neuer Führungskräfte für Elixicure an, womit das Unternehmen seinen Einstieg in den 11 Milliarden Dollar schweren Markt für topische Schmerzlinderungsmittel markiert. Laut der Forschung von Future Market Insights wird ein CAGR-Wachstum von 5,6% im globalen Bedarf an topischen Schmerzlinderungsmitteln erwartet, der bis 2034 ein Volumen von 19 Milliarden Dollar erreichen soll. Jeff Byrne und Don Dedo stoßen als Schlüsselexekutiven dazu, um die Expansion und Marktpräsenz von Elixicure voranzutreiben, was das Engagement von Rodedawg für Wachstum und Erfolg in der Branche widerspiegelt.
Positive
  • None.
Negative
  • None.

Rodedawg enters into 11 Billion dollar topical pain relief market

COSTA MESA, Calif., April 23, 2024 (GLOBE NEWSWIRE) -- Rodedawg International Industries, Inc. (OTC: RWGI) is pleased to announce the appointment of new officers to lead its subsidiary, Elixicure, Inc.

Elixicure

Chris Swartz, CEO, states: “Last year, Rodedawg acquired Elixicure’s assets of brands, manufacturing equipment, trade secrets, and online stores. According to Future Market Insights research, as the world continues to face chronic pain disorder burden, efficient and relieving topical pain relief becomes paramount for managing this condition. Given this, global demand for topical pain relief is anticipated to surge at a 5.6% CAGR through 2034. The market value is projected to increase from US$ 11 billion in 2024 to US$ 19 billion by 2034. The market was valued at US$ 10 billion in 2023 and is anticipated to exhibit a Y-o-Y growth of 5.2% in 2024. With this kind of growth and opportunity, the Company is now ready to rapidly expand Elixicure.” Effective immediately, the following executives will assume key roles:

*Jeff Byrne joins as the new Head of Operations for Elixicure, Inc. With a proven track record in operational management, Jeff will be instrumental in driving efficiency and excellence in Elixicure's day-to-day functions.

*Don Dedo assumes the responsibility of overseeing online sales, affiliates sales, and international sales for Elixicure, Inc. His extensive experience in sales and marketing will be pivotal in expanding Elixicure's reach and market presence.

These appointments reflect Rodedawg Ind. Intl., Inc.'s commitment to strengthening its leadership team and positioning Elixicure, Inc. for continued growth and success in the topical pain relief industry.

“We are thrilled to welcome Jeff Byrne and Don Dedo to lead Elixicure, Inc. Their leadership and expertise will play a vital role in driving Elixicure's growth and success,” said Chris Swartz, CEO of Rodedawg International Industries, Inc. “We are confident that with their guidance, Elixicure, Inc. will continue to thrive in the evolving cannabis market.”

To help oversee and manage Rodedawg Operations, John Stippick will be bringing his expertise to further enhance operational effectiveness within the organization.

Chris Swartz, concludes, “Rodedawg International Industries, Inc. remains dedicated to growth through management services, acquisitions, and restructuring resources throughout the regulated California cannabis market. The company continues to uphold its commitment to delivering value to shareholders and driving growth opportunities within the industry. Our team will continue to provide updates on our key initiatives for share cancellation, key acquisitions, and upcoming audit initiative.”

About Rodedawg International Industries, Inc.

Rodedawg International Industries, Inc. (OTC: RWGI) is focused on providing management services, acquisitions, and restructuring resources throughout the regulated California cannabis market. We are a trusted partner and asset to licensed cultivation, distributors, manufacturers, and retail dispensaries.

Please note the company's Twitter address is https://twitter.com/RWGImerger for regular updates.

About Budding Horizon, LLC

Budding Horizon, LLC is a California Limited Liability Company with offices in Orange County, California. The company is focused to providing management services for the licensed cannabis industry and seeks to leverage its expertise in the real estate acquisitions to acquire and develop a portfolio of assets.

The company website is https://buddinghorizon.com/

About Brother Buds™

Brother Buds is a cannabis delivery service based in Costa Mesa, California. During the month of July 2023, the Rodedawg will operate Brother Buds under a non-storefront cannabis delivery license. The cannabis delivery service will focus on Los Angeles County, Orange County, and norther San Diego County in the demographic area of 23.86 million in 2019. The company is focused to providing management services for the licensed cannabis industry and seeks to leverage its expertise in the real estate acquisitions to acquire and develop a portfolio of assets.

The company website is https://BrotherBuds.com

Make sure to follow us at: https://twitter.com/BrotherBudsOC

About Elixicure

Elixicure is a leading provider of manufacturing and capsule encapsulation services. We offer a wide range of services to meet the diverse needs of our clients, including capsule encapsulation, formulation, manufacturing, labeling and bottle filling. Our state-of-the-art facilities and experienced team of professionals allow us to deliver high-quality products and exceptional customer service. Whether you are looking for small-scale or large-scale production, we have the expertise and capabilities to meet your needs. Contact us today to learn more about how we can support your manufacturing and encapsulation needs.

The company website is https://elixicure.com/

Make sure to follow us at: https://twitter.com/Elixicure

Contact Information:

Rodedawg International Industries, Inc.
1-800-793-0355
ir@buddinghorizon.com

Safe Harbor Statement: In addition to historical information, this press release may contain statements that constitute forward-looking statements within the meaning of the Securities Act of 1933 and the Securities Exchange Act of 1934, as amended by the Private Securities Litigation Reform Act of 1995. Forward-looking statements contained in this press release include the intent, belief, or expectations of the Company and members of its management team with respect to the Company's future business operations and the assumptions upon which such statements are based. Prospective investors are cautioned that any such forward-looking statements are not guarantees of future performance, and involve risks and uncertainties, and that actual results may differ materially from those contemplated by such forward-looking statements. Factors that could cause these differences include, but are not limited to, failure to complete anticipated sales under negotiations, lack of revenue growth, client discontinuances, failure to realize improvements in performance, efficiency and profitability, and adverse developments with respect to litigation or increased litigation costs, the operation or performance of the Company's business units or the market price of its common stock. Additional factors that would cause actual results to differ materially from those contemplated within this press release can also be found on the Company's website. The Company disclaims any responsibility to update any forward-looking statements.

SOURCE: Rodedawg International Industries, Inc.

A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/5a721635-b40e-4aef-af40-690b061adf61


FAQ

What market is Rodedawg International Industries, Inc. entering with the appointment of new officers for Elixicure, ?

Rodedawg International Industries, Inc. is entering the $11 billion topical pain relief market.

What is the projected growth rate for global demand in topical pain relief according to Future Market Insights research?

Future Market Insights research projects a 5.6% CAGR growth in global topical pain relief demand, reaching $19 billion by 2034.

Who are the new executives appointed to key roles at Elixicure, Inc.?

Jeff Byrne joins as the new Head of Operations, and Don Dedo assumes responsibilities for sales and marketing at Elixicure, Inc.

What is Rodedawg International Industries, Inc.'s commitment with the new appointments?

The appointments reflect Rodedawg's commitment to strengthening its leadership team and positioning Elixicure, Inc. for continued growth and success in the topical pain relief industry.

What is the CEO of Rodedawg International Industries, Inc., Chris Swartz's statement regarding the new appointments?

Chris Swartz stated that the new executives' leadership and expertise will play a vital role in driving Elixicure's growth and success.

Rodedawg International Industries, Inc.

OTC:RWGI

RWGI Rankings

RWGI Latest News

RWGI Stock Data

6.71M
Automobile Manufacturing
Manufacturing
Link
United States of America
Sheridan